Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligenceBLOOD CANCER JOURNALIF11.62024-08-070OAAI
Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challengesFRONTIERS IN IMMUNOLOGYIF5.92024-06-131OAAI
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (vol 12, 13057, 2022)SCIENTIFIC REPORTSIF3.92024-03-280OAAI
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsFRONTIERS IN IMMUNOLOGYIF5.92024-01-100OAAI
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients (vol 14, 1188818, 2023)FRONTIERS IN IMMUNOLOGYIF5.92023-08-160OAAI
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsFRONTIERS IN IMMUNOLOGYIF5.92023-06-055OAAI
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTLEUKEMIAIF13.42023-01-0318OA
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNASCIENTIFIC REPORTSIF3.92022-07-2911OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向